DBD vs NOVT
As of Sep 20, 2026, DIEBOLD NIXDORF (DBD) scores 6.8/10 and Novanta (NOVT) 4.9/10 on AlphaStocks' five-model composite, so DBD scores higher. DBD trades 13% above its model fair value; NOVT trades 90% above its model fair value.
DBD
DIEBOLD NIXDORF, Inc
6.8
Consider Buy
$63.32
NOVT
NOVANTA INC
4.9
Weak
$133.01
DBD vs NOVT: Which is the Better Investment?
DIEBOLD NIXDORF, Inc (DBD) scores 6.8/10 while NOVANTA INC (NOVT) scores 4.9/10 on AlphaStocks' composite model. DIEBOLD NIXDORF, Inc has the higher composite rating of Consider Buy. On a P/E basis, DIEBOLD NIXDORF, Inc trades at 24.9x, making it the more attractively priced of the two.
This comparison is algorithmically generated and is not financial advice.
| Metric | DBD | NOVT |
|---|---|---|
| Scores & Fundamentals | ||
| Composite Score | 6.8/10▲ | 4.9/10 |
| Rating | Consider Buy▲ | Weak |
| Price | $63.32 | $133.01 |
| P/E Ratio | 24.9▲ | 90.7 |
| ROE | 8.6%▲ | 5.1% |
| Market Cap | $2B | $5B |
| Fair Value | $56.16 | $70.11 |
| Dividend Yield | — | — |
| Sector Rank | #37 of 205▲ | #129 of 205 |
| Model Verdicts | ||
| Piotroski | Strong▲ | Attractive |
| Buffett | Attractive▲ | Neutral |
| Graham | Caution | Neutral▲ |
| Lynch | Attractive▲ | Neutral |
| Greenblatt | Strong▲ | Caution |
Related comparisons
DBD vs NOVT: Which Stock Scores Higher?
DIEBOLD NIXDORF, Inc (DBD) and NOVANTA INC (NOVT) are both in the Information Technology sector. DBD currently leads with a composite score of 6.8/10 (Consider Buy) compared to NOVT's 4.9/10 (Weak).
The AlphaStocks composite score evaluates each stock across four dimensions: Quality (business strength measured by Piotroski F-Score and Buffett quality criteria), Value (discount to intrinsic worth using Graham, Lynch, and Greenblatt models), Momentum (6-month price trend), and Timing (a confirmation signal that requires both value and momentum to align). A higher composite score indicates stronger overall fundamentals combined with favorable market conditions.
This comparison uses the same scoring framework for both companies, ensuring an apples-to-apples evaluation. Scores are recalculated daily after market close using data from SEC filings and market prices. Read the full methodology to understand how each model contributes to the composite score.
Scores are algorithm-generated research tools, not investment recommendations. Past performance does not guarantee future results. Always do your own due diligence. Full disclaimer